EUVIMEDEUVIMED entdecken
Crossref

Non-gynecologic Ovarian Metastases: A Clinicopathologic and Immunophenotypic Study of 29 Cases

Hanife Seda Mavili, Ömer Atmış, Fatma Seher Pehlivan, Bağdagül Nur Doğan

OSMANGAZİ JOURNAL OF MEDICINE · 09.06.2026 · 48 (4) · 654-667

DOI: 10.20515/otd.1905549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OSMANGAZİ JOURNAL OF MEDICINE, online erschienen am 09.06.2026. Verfasst von Hanife Seda Mavili und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Gefördert von: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic tumors represent a substantial proportion of ovarian malignancies and may mimic primary ovarian neoplasms, posing significant diagnostic challenges. This study aimed to evaluate the clinicopathologic, morphologic, and immunohistochemical features of ovarian metastases from non-gynecologic primary tumors to facilitate identification of the primary tumor site. A retrospective analysis of 29 metastatic ovarian tumors diagnosed at a tertiary center was performed. Clinical data, tumor laterality, timing of metastasis, morphologic patterns, and immunohistochemical profiles were reviewed. Colorectal carcinoma was the most frequent primary tumor (41.4%), followed by gastric (20.7%), pancreaticobiliary (20.7%), and breast carcinomas (17.2%). Bilateral ovarian involvement and diffuse infiltrative growth with desmoplastic stroma were common findings. Colorectal metastases commonly exhibited tubuloglandular architecture with necrosis, whereas gastric tumors were characterized by signet-ring cell morphology. Immunohistochemical analysis revealed lineage-associated profiles: the CK7−/CK20+ pattern supported colorectal origin, whereas CK7+/CK20− favored breast carcinoma. The use of lineage-specific markers, including SATB2, ER/PR, and GATA3, improved diagnostic specificity. Integration of morphologic evaluation with CK7/CK20 immunophenotypic patterns and lineage-specific markers provides a practical framework for identifying the primary tumor in metastatic ovarian lesions.

Förderung

  • This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Zitieren

APA

Mavili, H. S., Atmış, Ö., Pehlivan, F. S., & Doğan, B. N. (2026). Non-gynecologic Ovarian Metastases: A Clinicopathologic and Immunophenotypic Study of 29 Cases. OSMANGAZİ JOURNAL OF MEDICINE, 48(4), 654-667. https://doi.org/10.20515/otd.1905549

Vancouver

Mavili HS, Atmış Ö, Pehlivan FS, Doğan BN. Non-gynecologic Ovarian Metastases: A Clinicopathologic and Immunophenotypic Study of 29 Cases. OSMANGAZİ JOURNAL OF MEDICINE. 2026;48(4):654-667. doi:10.20515/otd.1905549

BibTeX
@article{Mavili2026,
  author = {Mavili, Hanife Seda and Atmış, Ömer and Pehlivan, Fatma Seher and Doğan, Bağdagül Nur},
  title = {Non-gynecologic Ovarian Metastases: A Clinicopathologic and Immunophenotypic Study of 29 Cases},
  journal = {OSMANGAZİ JOURNAL OF MEDICINE},
  year = {2026},
  volume = {48},
  number = {4},
  pages = {654--667},
  doi = {10.20515/otd.1905549}
}
Kostenlos starten →